| N | ≤4 h N = 23 | > 4 h N = 154 | P |
---|---|---|---|---|
Age (years) | 177 | 74.00 [60.00;82.00] | 71.00 [65.00;77.00] | 0.964 |
Gender, n (%) | 177 | Â | Â | 0.316 |
 Female | 22 | 1 (4.35%) | 21 (13.64%) |  |
 Male | 155 | 22 (95.65%) | 133 (86.36%) |  |
BMI (kg/m2) | 175 | 29.40 [26.30;32.30) | 30.10 [26.95;34.40] | 0.379 |
SA sub-groups, n (%) | 177 |  |  | < 0.001 |
 CSA | 105 | 6 (26.09%) | 99 (64.29%) |  |
 OSA | 36 | 6 (26.09%) | 30 (19.48%) |  |
 TESA | 36 | 11 (47.83%) | 25 (16.23%) |  |
Initial exam, n (%) | 177 | Â | Â | 0.692 |
 PG | 101 | 14 (60.87%) | 87 (56.49%) |  |
 PSG | 76 | 9 (39.13%) | 67 (43.51%) |  |
Initial AHI (n/h) | 177 | 50.00 [40.00;67.20] | 50.00 [38.00;60.30] | 0.636 |
Final AHIflow | 177 | 2.00 [0.80;5.20] | 1.85 [0.70;3.60] | 0.362 |
Initial ESS score | 136 | 12.50 [9.00;16.00] | 9.00 [5.00;13.00] | 0.012 |
Final ESS score | 174 | 8.50 [4.00;12.00] | 5.00 [3.00;9.00] | 0.034 |
Initial ESS-final ESS score | 136 | 2 (0.00–6.00) | 2.50 (0.00–7.00) | 0.775 |
ASV initiation during continuous hospitalization, n (%) | 173 | 13 (61.90%) | 65 (42.76%) | 0.098 |
CPAP trial before ASV initiation, n (%) | 166 | 16 (69.57%) | 75 (52.45%) | 0.126 |
Interface Type, n (%) | 175 | Â | Â | Â |
 Facial | 87 | 12 (52.17%) | 75 (49.34%) | 0.800 |
 Nasal/Nasal Pillows | 88 | 11 (47.83%) | 77 (50.66%) |  |
Cardiological comorbidity/etiology, n (%) | 177 | 18 (78.26%) | 116 (75.32%) | 0.759 |
Neurological comorbidity/etiology, n (%) | 177 | 0 (0.00%) | 22 (14.29%) | 0.053 |
Renal comorbidity/etiology, n (%) | 177 | 2 (8.70%) | 6 (3.90%) | 0.278 |
Opiod comorbidity/etiology, n (%) | 177 | 0 (0.00%) | 6 (3.90) | 0.336 |
Idiopathic CSA, n (%) | 177 | 2 (8.70%) | 15 (9.74%) | 1.000 |
No comorbidity/etiology, n (%) | 177 | 5 (21.74%) | 28 (18.18%) | 0.774 |
Patients with at least one hospitalization for cardiologic cause, n (%) | 177 | 3 (13.04%) | 8 (5.19%) | 0.157 |
Number of cardiological medications | 169 | 3.00 [1.00;4.00] | 2.00 [1.00;3.00] | 0.535 |
Knowledge of the medical treatment by the patient, n (%) | 162 | 8 (40.00%) | 83 (58.45%) | 0.119 |
Echocardiography or cardiological consultation in the last 6 months, n (%) | 144 | 11 (64.71%) | 65 (51.18%) | 0.294 |
Oxymetry or Polygraphy ASV control in the last 6 months | 157 | 2 (10.00%) | 52 (37.96%) | 0.014 |
Modification of ASV settings as a consequence of Polygraphy or oximetry, n (%) | 54 | 0 (0%) | 14 (26.92%) | 1.000 |